Orlando, FL - Results of a randomized trial show that simvastatin, but not pravastatin, appears to interfere with sleep quality and increase sleep problems, as assessed by patients. "Simvastatin users ...
Dallas, TX - The HMG Co-A reductase inhibitors simvastatin (Zocor® - Merck), atorvastatin (Lipitor® - Pfizer), and pravastatin (Pravachol® - Bristol Myers Squibb) all reduce high-sensitive C-reactive ...
Among the 20 leading prescription drugs in the United States, 3 agents-atorvastatin (Lipitor), simvastatin (Zocor), and pravastatin (Pravachol)-are of the class known formally as ...
People taking statins face an increased risk of developing diabetes, warn researchers. They found a 10 per cent extra risk linked to taking simvastatin – the most commonly prescribed anti-cholesterol ...
Treatment with high potency statins (especially atorvastatin and simvastatin) may increase the risk of developing diabetes, suggests a new article. Treatment with high potency statins (especially ...
A popular drug used to keep cholesterol in check might be interfering with a good night's sleep, U.S. researchers said on Wednesday. A large study looking at sleep patterns of people who took the ...
Although lowering blood pressure (BP) reduces aortic stiffness, achieving the recommended BP goal can be difficult. Recent studies have shown that short-term use of statins can reduce BP significantly ...
Simvastatin and pravastatin are inhibitors of 3-hydroxy-3-methylglutaryl CoA reductase, and are used as antihypercholesterolemia drugs. Simvastatin, but not pravastatin, binds to the inserted domain ...
Efficacy of switching statin therapy from generic simvastatin was examined in a VA population. Ezetimibe/simvastatin was more potent than atorvastatin or rosuvastatin in lowering LDL. Treatment of ...
Certain statins – also known as cholesterol-lowering medications – could increase your risk of developing type 2 diabetes, a new study suggests. The risk was most significant in patients taking ...
Kyoto, Japan, Monday 29 September 2003. New data presented at the XIIIth International Symposium on Atherosclerosis (ISA) show AstraZeneca's highly effective statin CRESTOR (rosuvastatin) achieves ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback